Medicon Hellas SA
ATHEX:MEDIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medicon Hellas SA
Revenue
Medicon Hellas SA
Revenue Peer Comparison
Medicon Hellas SA
Glance View
Medicon Hellas SA engages in the business of medical technology. The company is headquartered in Athina, Attiki. The company went IPO on 2001-07-11. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.
See Also
What is Medicon Hellas SA's Revenue?
Revenue
18.3m
EUR
Based on the financial report for Jun 30, 2025, Medicon Hellas SA's Revenue amounts to 18.3m EUR.
What is Medicon Hellas SA's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Medicon Hellas SA have been -6% over the past three years , 7% over the past five years , and 5% over the past ten years .
